Cargando…

Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials

Background: Sleep disorders are one of the most frequent non-motor symptoms of Parkinson's disease (PD), and the efficacy of dopaminergic agents remains controversial. Clinical randomized control trials for the treatment of sleep disorders in PD are limited. Zonisamide (1,2-benzisoxazole-3-meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataoka, Hiroshi, Isogawa, Masahiro, Inoue, Takashi, Hasebe, Miyoko, Takashima, Ryuzo, Kasama, Shu, Nanaura, Hitoki, Kiriyama, Takao, Kasahara, Masato, Sugie, Kazuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713296/ https://www.ncbi.nlm.nih.gov/pubmed/34970203 http://dx.doi.org/10.3389/fneur.2021.741307

Ejemplares similares

Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Anti-programmed cell death-1 (PD-1) monoclonal antibodies involve reversible cranial dura matter
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Risk of Unsuccessful Noninvasive Ventilation for Acute Respiratory Failure in Heterogeneous Neuromuscular Diseases: A Retrospective Study
por: Kataoka, Hiroshi, et al.
Publicado: (2017)

Accidental hypothermia in Parkinson’s disease
por: Kataoka, Hiroshi, et al.
Publicado: (2018)

Serum Alkaline Phosphatase in Cryptogenic Stroke Cases with Active Cancer
por: Izumi, Tesseki, et al.
Publicado: (2022)

A Patient With Encephalomyeloradiculoneuropathy Exhibiting a Relapsing–Remitting Clinical Course: Correlation of Serum and Cerebrospinal Fluid Anti-Neutral Glycosphingolipids Antibodies With Clinical Relapse
por: Nanaura, Hitoki, et al.
Publicado: (2018)

Religious zeal as an affective phenomenon
por: Tietjen, Ruth Rebecca
Publicado: (2020)

C9orf72-Derived Proline:Arginine Poly-Dipeptides Modulate Cytoskeleton and Mechanical Stress Response
por: Shiota, Tomo, et al.
Publicado: (2022)

Journeyman undermined by zeal for mass appeal
por: Anderson, Don
Publicado: (2005)

Effect of galvanic vestibular stimulation on axial symptoms in Parkinson’s disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Mitral Valve Replacement for Enlarged Libman-Sacks Endocarditis in a Patient with Persistent Primary Antiphospholipid Syndrome and Recurrent Stroke: A Case Report
por: Takeuchi, Katsuya, et al.
Publicado: (2023)

High-dose steroid-responsive COVID-19-related encephalopathy with a sudden onset of dysarthria mimicking stroke: a case report
por: Kikutsuji, Naoya, et al.
Publicado: (2022)

Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson's Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2012)

Religious Zeal, Affective Fragility, and the Tragedy of Human Existence
por: Tietjen, Ruth Rebecca
Publicado: (2021)

ZEAL: protein structure alignment based on shape similarity
por: Ljung, Filip, et al.
Publicado: (2021)

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

Pain-Related Abnormal Neuronal Synchronization of the Nucleus Accumbens in Parkinson’s Disease
por: Kinugawa, Kaoru, et al.
Publicado: (2022)

Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)
por: Castro, Mario, et al.
Publicado: (2021)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Delusional Jealousy (Othello Syndrome) in 67 Patients with Parkinson’s Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2018)

A zeal for responsibility: the struggle for professional nursing in Victorian England, 1868–1883
por: Hall, Lesley
Publicado: (1990)

Zonisamide effects on sleep problems and depressive symptoms in Parkinson’s disease
por: Suzuki, Keisuke, et al.
Publicado: (2021)

Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Feasibility and acceptability of novel functional electronic stimulated rehabilitation application for treatment in patients with cerebrovascular disorders: the FRAT study protocol
por: Mano, Tomoo, et al.
Publicado: (2022)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Polysomnographic and Clinical Parameters before and after Zonisamide Therapy for Parkinson's Disease
por: Miyaue, Noriyuki, et al.
Publicado: (2022)

Abnormal Behavior Episodes Associated With Zonisamide in Three Dogs: A Case Report
por: Kanazono, Shinichi, et al.
Publicado: (2021)

Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease
por: Grover, Neeta D., et al.
Publicado: (2013)

Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease
por: Nishijima, Haruo, et al.
Publicado: (2018)

Genome-wide association study identifies zonisamide responsive gene in Parkinson’s disease patients
por: Cha, Pei-Chieng, et al.
Publicado: (2020)

Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
por: Sano, Hiromi, et al.
Publicado: (2023)

Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits
por: Matar, Kamal M.
Publicado: (2013)

Repositioning again of zonisamide for nerve regeneration
por: Ohno, Kinji, et al.
Publicado: (2016)

Zonisamide-induced acute kidney injury
por: Dixit, Deepali, et al.
Publicado: (2015)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Zonisamide-Induced Hallucinations: An Anticonvulsant’s Psychosis
por: Al Armashi, Abdul Rahman, et al.
Publicado: (2021)

Neural synchronization analysis of electroencephalography coherence in patients with Parkinson’s disease-related mild cognitive impairment
por: Mano, Tomoo, et al.
Publicado: (2022)

Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study
por: Murata, Miho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p727pppqktvom2vljjvp57fknq